These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 3657706

  • 1. Radionuclide therapy of neural crest tumors.
    Voûte PA, Hoefnagel CA, de Kraker J, Evans AE, Hayes A, Green A.
    Med Pediatr Oncol; 1987; 15(4):192-5. PubMed ID: 3657706
    [Abstract] [Full Text] [Related]

  • 2. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA, Hoefnagel CA, de Kraker J.
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [Abstract] [Full Text] [Related]

  • 3. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L, Rufini V.
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives.
    Beierwaltes WH.
    Med Pediatr Oncol; 1987; 15(4):188-91. PubMed ID: 3657705
    [Abstract] [Full Text] [Related]

  • 10. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M, Shinohara S.
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
    Troncone L, Rufini V, Montemaggi P, Danza FM, Lasorella A, Mastrangelo R.
    Eur J Nucl Med; 1990 Apr; 16(4-6):325-35. PubMed ID: 2351179
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
    Okazawa H, Endo K, Saga T, Watanabe Y, Nakai T, Kasagi K, Konishi J, Abe M, Goto K, Nakao K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar 25; 50(3):286-94. PubMed ID: 2345700
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A case of malignant pheochromocytoma treated by 131I-metaiodobenzylguanidine.
    Theilade K, Bak M, Olsen K, Nielsen SL, Christensen NJ.
    Acta Oncol; 1988 Mar 25; 27(3):296-7. PubMed ID: 3415861
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
    Mukherjee JJ, Kaltsas GA, Islam N, Plowman PN, Foley R, Hikmat J, Britton KE, Jenkins PJ, Chew SL, Monson JP, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 2001 Jul 25; 55(1):47-60. PubMed ID: 11453952
    [Abstract] [Full Text] [Related]

  • 19. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
    Fischer M.
    Bildgebung; 2001 Jul 25; 56(4):141-5. PubMed ID: 3271589
    [Abstract] [Full Text] [Related]

  • 20. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    Shapiro B, Sisson JC, Shulkin BL, Gross MD, Zempel S.
    Q J Nucl Med; 1995 Dec 25; 39(4 Suppl 1):55-7. PubMed ID: 9002750
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.